Iron-refractory iron deficiency anemia (IRIDA)

Area of Science:

• Genetics
• Hematology
• Human Physiology

Background:

• Iron deficiency anemia (IDA) is a prevalent global health issue, commonly linked to diet or blood loss.
• Familial cases of IDA unresponsive to oral iron and partially responsive to parenteral iron suggest a genetic basis.
• The TMPRSS6 gene has been identified as a key factor in a subset of these refractory IDA cases.

Purpose of the Study:

• To review the clinical manifestations of iron-refractory iron deficiency anemia (IRIDA).
• To discuss recent genetic findings related to IRIDA.
• To explore the implications of IRIDA for understanding systemic iron homeostasis regulation.

Main Methods:

• Literature review of clinical and genetic studies on IRIDA.
• Analysis of patient kindreds with mutations in the TMPRSS6 gene.
• Synthesis of current knowledge on iron metabolism and its regulation.

Main Results:

• IRIDA is a distinct clinical entity characterized by severe anemia resistant to iron therapy.
• Mutations in the TMPRSS6 gene are causative in many IRIDA cases.
• IRIDA provides valuable insights into the complex mechanisms governing iron balance in the body.

Conclusions:

• IRIDA represents a significant genetic cause of refractory iron deficiency anemia.
• Understanding IRIDA pathogenesis enhances our knowledge of systemic iron regulation.
• Genetic testing for TMPRSS6 mutations is crucial for diagnosing IRIDA.